J01DD04 • ceftriaxone • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins
Ceftriaxone is a third-generation cephalosporin antibiotic used to treat severe bacterial infections, including meningitis, pneumonia, intra-abdominal infections, urinary tract infections, and sepsis. It is effective against a wide range of gram-negative and gram-positive bacteria.
The medication is administered intravenously or intramuscularly, and the dosage is adjusted based on the severity of the infection, the patient's weight, and renal function. Ceftriaxone is frequently used in hospitals for complicated infections or for patients at high risk of severe infections.
Patients should be closely monitored during treatment to detect potential side effects, such as allergic reactions, diarrhea, or liver toxicity. It is important for patients to complete the treatment as directed by their doctor.
Side effects may include nausea, diarrhea, skin rashes, or, in rare cases, severe reactions such as anaphylactic shock or hematological disorders. Patients should inform their doctor of any unusual symptoms.
Substance: ceftriaxone
Date of last drug list: 01-07-2013
Commercial code: W51696001
Concentration: 250mg
Pharmaceutical form: powder for intramuscular / intravenous injection solution
Quantity: 50
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).